Top Markets
#1 Akedo Akedo +57.68%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.31%
#4 Cross Cross +43.97%
#5 OVERTAKE OVERTAKE +34.90%
#6 Black Phoenix Black Phoenix +34.01%
#7 Velvet Velvet +27.53%
#8 Cap Cap +15.60%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.31%
#10 Palladium Network Palladium Network +12.56%
Coin of the day
Akedo Akedo
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Rang in aandelen #38693
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Aandeelprijs
$0.0601
Marktkapitalisatie
$699.79K
Verandering (1 dag)
-14.14%
Verandering (1 jaar)
0.17%
Land
US
Handel Hepion Pharmaceuticals, Inc. (HEPA)

Categorie

Healthcare
Aandelsplitsingen voor Hepion Pharmaceuticals, Inc. (HEPA)
Het aandeel Hepion Pharmaceuticals, Inc. (symbool: HEPA) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 14, 2026.
Eén aandeel HEPA dat vóór Aug 14, 2026 werd gekocht, staat nu gelijk aan 0 aandelen HEPA.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE